Inkocell Therapeutics Revenue

Pharmaceutical Manufacturing • Switzerland • 1-10 Employees

Inkocell Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$547,552
Total funding	$188,300

Key Contact at Inkocell Therapeutics

Mathieu Girardin

Co-Founder

Company overview

Headquarters	Switzerland
NAICS	3254
Keywords	Cancer, Fibrotic Diseases, Car-Nk, Chimeric Antigen Receptor (Car), Natural Killer (Nk), Autoimmunities
Employees	1-10
Socials

About Inkocell Therapeutics

While CAR-T therapies have transformed cancer treatment, they remain complex, expensive, and often associated with serious side effects. Moreover, many patients still fail to respond. There is an urgent need for new approaches that are safer, more accessible, and more broadly applicable. Inkocell Therapeutics has developed an NK-tailored CAR receptor, specifically engineered for NK cells, rather than adapting T-cell designs. This innovation enhances NK-cell activity, creating a powerful new generation of therapies. Inkocell’s approach is off-the-shelf and scalable, lowering costs while broadening access for patients. Inkocell is advancing two lead programs: the first targets B-cell malignancies, while the second aims to overcome resistance in solid tumors. Together, they provide a foundation for future expansion into autoimmune and fibrotic diseases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Inkocell Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Inkocell Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-24	13	N/A
2025-10-08	9	$188,300

Funding Insights

$188,300

Total funding amount

$188,300

Most recent funding amount

Number of funding rounds

Frequently asked questions

Inkocell Therapeutics is located in CH.

Inkocell Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Inkocell Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Inkocell Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Inkocell Therapeutics has raised a total of $188,300 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Inkocell Therapeutics

Mathieu Girardin

Co-Founder

4.8

40,000 users